Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aromatase inhibitor?
Displaying drugs 1776 - 1800 of 2447 in total
Experimental
Matched Categories: … Enzyme Inhibitors ... Electron Transport Complex III, antagonists & inhibitors
Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).
Investigational
Matched Categories: … Enzyme Inhibitors ... Protein Kinase Inhibitors
N-chlorotaurine is an inhibitor of inducible nitric oxide synthase and IkappaB kinase.
Investigational
Matched Categories: … Enzyme Inhibitors ... Protein-Serine-Threonine Kinases, antagonists & inhibitors
Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Investigational
Matched Categories: … Enzyme Inhibitors ... Thromboxane-A Synthase, antagonists & inhibitors
Entinostat is under investigation for the treatment and other of Volunteers, Breast Cancer, Human Volunteers, and Normal Volunteers. Entinostat has been investigated for the treatment of Non-Small Lung Cancer, Epigenetic Therapy.
Investigational
Matched Categories: … Enzyme Inhibitors ... Histone Deacetylase Inhibitors ... Histone deacetylase (HDAC) inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors
Investigational
Matched Categories: … Enzyme Inhibitors ... Reverse Transcriptase Inhibitors ... Nucleic Acid Synthesis Inhibitors ... Non-Nucleoside Reverse Transcriptase Inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Protein Synthesis Inhibitors ... Histone Deacetylase Inhibitors
Tarenflurbil is an investigational drug that was studied in patients with mild Alzheimer's disease. It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta 42 (Aβ42) in cultured human cells and in animal models. Aβ42 is the primary initiator of neurotoxicity and amyloid...
Investigational
Matched Categories: … Enzyme Inhibitors ... Cyclooxygenase Inhibitors ... Gamma Secretase Inhibitors and Modulators …
Experimental
Matched Categories: … Enzyme Inhibitors ... 5'-Nucleotidase, antagonists & inhibitors
Experimental
Matched Categories: … RNA Replicase, antagonists & inhibitors ... RNA-Dependent RNA Polymerase, antagonists & inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Neuraminidase Inhibitors
Specific inhibitor of phosphatidylinositol 3-kinase.
Experimental
Matched Categories: … Enzyme Inhibitors ... Phosphatidylinositol 3-Kinases, antagonists & inhibitors
Investigational
Matched Categories: … Enzyme Inhibitors ... Protein Kinase Inhibitors
Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone. It strongly inhibits the DNA-supercoiling activity of DNA gyrase. Fleroxacin is not an inhibitor of CYP1A2.
Experimental
Matched Categories: … Enzyme Inhibitors ... Topoisomerase Inhibitors ... Topoisomerase II Inhibitors
Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class. Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones. Several analogues were later developed, some of which—such as pioglitazone and troglitazone—made it to the market....
Experimental
Matched Categories: … Cytochrome P-450 CYP2C8 Inhibitors ... Cytochrome P-450 Enzyme Inhibitors ... Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) …
Experimental
Matched Categories: … Enzyme Inhibitors ... Protease Inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Phosphodiesterase Inhibitors
Fimepinostat (CUDC-907) has been used in trials studying the treatment of lymphoma, solid tumors, breast cancer, multiple myeloma, and NUT midline carcinoma, among others.
Investigational
Matched Categories: … Histone Deacetylase Inhibitors ... Phosphatidylinositol 3-Kinases, antagonists & inhibitors
Foretinib has been used in trials studying the treatment of Cancer, Breast Cancer, Carcinoma, Renal Cell, Recurrent Breast Cancer, and Neoplasms, Head and Neck, among others. Foretinib is an orally available small molecule compound designed to target multiple RTKs implicated in the development, progression and spread of cancer. It inhibits...
Investigational
Matched Categories: … Tyrosine Kinase Inhibitors ... Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors
KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).
Investigational
Matched Categories: … Enzyme Inhibitors ... Protein Synthesis Inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... BCRP/ABCG2 Inhibitors
EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.
Investigational
Matched Categories: … Enzyme Inhibitors ... Phosphodiesterase Inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Calcium-Transporting ATPases, antagonists & inhibitors
Fialuridine is under investigation in clinical trial NCT01337466 (Biodistribution and Dosimetry Evaluation of [124I]FIAU).
Investigational
Matched Categories: … Enzyme Inhibitors ... Nucleic Acid Synthesis Inhibitors
Displaying drugs 1776 - 1800 of 2447 in total